# Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)

> **NCT03680183** · — · UNKNOWN · sponsor: **Affiliated Cancer Hospital & Institute of Guangzhou Medical University** · enrollment: 300 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer
- Hepatitis B

## Interventions

- **DRUG:** Entecavir 1Mg Oral Tablet

## Key facts

- **NCT ID:** NCT03680183
- **Lead sponsor:** Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-22
- **Primary completion:** 2019-03-01
- **Final completion:** 2021-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2018-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03680183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03680183, "Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03680183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*